Navigation Links
OL1000 Bone Growth Stimulators

ProductsOL1000 Bone Growth Stimulators
Company DJO Incorporated
Item OL1000 Bone Growth Stimulators
Features 
  • Light-weight and comfortable
  • Easy-to-use & Noninvasive
  • Requires simple, one-button operation
  • Can be used with internal or external fixation or over a cast
  • This treatment has been shown in pre-clinical studies to help the bodys own healing process begin working
Description OL1000 Bone Growth Stimulators are portable, battery-powered medical devices indicated for use in the noninvasive treatment of an established nonunion fracture acquired secondary to trauma, excluding all vertebrae and flat bones.

Clinical studies have shown an increased chance of healing of 60.7% in patients with nonunions that averaged 29.3 months from injury. Registry data on over 2300 patients reports a heal rate of 75.1%
Info DJO Incorporated
Customer Service: (888) 624-5450
Web site: http://www.djortho.com/

Related medicine products :

1. CMF OL1000 Bone Growth Stimulators
2. Autologous Growth Factors
3. IGF-1 EIA Endocrine Function 026-AC-27F1 Insulin Growth Factor
4. Human Growth Hormone EIA Endocrine Function 025-BC-1033
5. IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein
6. EBI OsteoGen Implantable Bone Growth Stimulator
7. Physio-Stim Bone Growth Stimulator
8. SpinaLogic Bone Growth Stimulator
9. OrthoPak Noninvasive Bone Growth Stimulator
10. STAT Growth-BP
11. Insulin-like Growth Factor-I (IGF-I) ELISA
Conducting disposable tips provide cross-contaminationfree pipetting for sensitive applications such as PCR setup....
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
... the Finntip Wide is designed especially for ... genomic DNA. This tip eliminates the mechanical ... excellent for use with extremely viscous liquids. ... of the orifice is 1.1 mm or ...
Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels...
Medicine Products:
(Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 Juvent ... today at the 2015 PGA Merchandise Show to bestow ... and incredible female amateur golfer, Arlene McKitrick. The award ... female amateur golf tournament win. She won her first ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz ... has treated just about every type of injury that can result ... those same twenty-plus years, the team at Doctors on Liens ... best possible doctor. With the combined breadth of experience ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Joan Lunden, ... keynote speaker at the upcoming 32nd Annual Miami ... Physicians’ Education Resource®, LLC (PER®) , shares that ... have gone undetected if she had not followed up ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... Match for Long-Term Care, GREENSBORO, N.C., ... announces that it successfully completed its,Discovery-180 technology ... Inc. ( http://www.foxlearningsystems.com ), a leading e-learning,organization ... is the innovator,of the Real Life, Real ...
... Enhance Collaboration and Partnership with CDC, CAMBRIDGE, ... and technical assistance firm, this month opened an ... services,to the U.S. Centers for Disease Control and ... substantial client of our firm for many years,",said ...
... going down the plughole: that,s how the British emerge from ... in Britain are particularly guilty of wasting shower water and ... Royal Society of Chemistry . , But men in Britain ... about what they wash down the drain. The most glaring ...
... join with Blue Cross and Blue Shield companies ... WASHINGTON, July 14 Recognizing that chronic,illness ... employers are,taking a "hands on" approach to improving ... smoking, obesity, and disease prevention,and management. At a ...
... CARLSBAD, Calif., July 14 The Chopra ... Deepak Chopra, M.D. and,David Simon, M.D. has ... -- a custom-blend oil treatment based on ... is the newest addition to The,Chopra Center,s ...
... first, scientists at Sydney,s Centenary Institute have mapped the ... the potential to turn the way we discover new ... for new treatments. , "These membrane proteins are the ... increased,understanding of them is vital for future drug discoveries," ...
Cached Medicine News:Health News:Fox Learning Systems Selects Prymak's Discovery-180(TM) Technology Assessment to Guide Search for New LMS 2Health News:Fox Learning Systems Selects Prymak's Discovery-180(TM) Technology Assessment to Guide Search for New LMS 3Health News:Abt Associates Opens Atlanta Office 2Health News:British showers most wasteful and inconsiderate in Western Europe 2Health News:Employers Take Active Role in Promoting Workplace Wellness 2Health News:Employers Take Active Role in Promoting Workplace Wellness 3Health News:The Chopra Center for Wellbeing Introduces Ayurnas: A Soothing Natural Remedy for Sinus Congestion, Chronic Headaches, and Cold Symptoms 2Health News:Discovery first step to new therapies 2
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2